Rubini Andrea, Zanotti Federica, Licastro Danilo, Calogero Giulia, Bettini Gisella, Piccoli Cristiana, Rubini Giuseppe, Lovatti Luca, Zavan Barbara
Ultravet Diagnostics, 40017, San Giovanni in Persiceto, Italy.
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Nanotheranostics. 2025 Jan 1;9(1):38-51. doi: 10.7150/ntno.99383. eCollection 2025.
Feline Idiopathic Cystitis (FIC), is a chronic lower urinary tract condition in cats analogous to PBS/IC in women, which presents significant treatment challenges due to its idiopathic nature. Recent advancements in regenerative medicine highlight the potential of Adipose Tissue-Derived Stem Cells (ADSCs), particularly through their secretome, which includes mediators, bioactive molecules, and extracellular vesicles (EVs). Notably, exosomes, a subset of EVs, facilitate cell-to-cell communication and, when derived from ADSCs, exhibit anti-inflammatory properties and contribute to tissue regeneration. In this work, we aim to characterize the content of exosomes derived from feline ADSCs (fADSCs) to elucidate their mechanisms of action on recipient cells and assess their therapeutic potential for FIC. Exosomes were isolated from fADSCs and their microRNA (miRNA) content sequenced using Illumina technology. Our findings demonstrate that fADSC-derived exosomes harbor miRNAs that can induce regenerative processes, such as cell proliferation, immune modulation, angiogenesis, and anti-inflammatory responses. Key miRNAs identified include fca-miR-221, fca-let-7f-5p, fca-miR-337-5p, fca-miR-542-5p, fca-miR-24-3p, fca-miR-205, and fca-miR-23a, which promote proliferative, angiogenic, differentiation, and regenerative mechanisms. Additionally, miRNAs with anti-inflammatory effects, such as fca-miR-193a-5p and fca-miR-127-3p, and those positively regulating the immune system, including fca-let-7a-5p and fca-miR-chrC1_18846-5p, were identified. Of particular interest, fca-miR-219-5p (has-miR-6766-3p) has been reported to suppress liver fibrosis.These results underline the therapeutic potential of fADSC-derived exosomes in treating FIC and suggest innovative strategies for feline veterinary medicine.
猫特发性膀胱炎(FIC)是猫的一种慢性下尿路疾病,类似于女性的间质性膀胱炎/膀胱疼痛综合征(PBS/IC),因其特发性本质而带来了重大的治疗挑战。再生医学的最新进展凸显了脂肪组织来源干细胞(ADSCs)的潜力,特别是通过其分泌组,其中包括介质、生物活性分子和细胞外囊泡(EVs)。值得注意的是,外泌体作为细胞外囊泡的一个子集,促进细胞间通讯,并且当来源于脂肪组织来源干细胞时,具有抗炎特性并有助于组织再生。在这项研究中,我们旨在表征猫脂肪组织来源干细胞(fADSCs)衍生的外泌体的内容物,以阐明其对受体细胞的作用机制,并评估其对猫特发性膀胱炎的治疗潜力。从猫脂肪组织来源干细胞中分离出外泌体,并使用Illumina技术对其微小RNA(miRNA)含量进行测序。我们的研究结果表明,猫脂肪组织来源干细胞衍生的外泌体含有能够诱导再生过程的微小RNA,如细胞增殖、免疫调节、血管生成和抗炎反应。鉴定出的关键微小RNA包括fca-miR-221、fca-let-7f-5p、fca-miR-337-5p、fca-miR-542-5p、fca-miR-24-3p、fca-miR-205和fca-miR-23a,它们促进增殖、血管生成、分化和再生机制。此外,还鉴定出具有抗炎作用的微小RNA,如fca-miR-193a-5p和fca-miR-127-3p,以及对免疫系统有正向调节作用的微小RNA,包括fca-let-7a-5p和fca-miR-chrC1_18846-5p。特别值得关注的是,fca-miR-219-5p(has-miR-6766-3p)据报道可抑制肝纤维化。这些结果强调了猫脂肪组织来源干细胞衍生的外泌体在治疗猫特发性膀胱炎方面的治疗潜力,并为猫兽医学提出了创新策略。